The document discusses colloidal bismuth subcitrate and treatments for H. pylori and peptic ulcers. It states that colloidal bismuth subcitrate causes prolonged neutralization of gastric acid. Eradication of H. pylori along with gastric antisecretory drugs provides faster ulcer healing and reduced chance of ulcer relapse. Anti-H. pylori therapy includes clarithromycin, tinidazole, and amoxicillin but not ciprofloxacin.
The document discusses colloidal bismuth subcitrate and treatments for H. pylori and peptic ulcers. It states that colloidal bismuth subcitrate causes prolonged neutralization of gastric acid. Eradication of H. pylori along with gastric antisecretory drugs provides faster ulcer healing and reduced chance of ulcer relapse. Anti-H. pylori therapy includes clarithromycin, tinidazole, and amoxicillin but not ciprofloxacin.
The document discusses colloidal bismuth subcitrate and treatments for H. pylori and peptic ulcers. It states that colloidal bismuth subcitrate causes prolonged neutralization of gastric acid. Eradication of H. pylori along with gastric antisecretory drugs provides faster ulcer healing and reduced chance of ulcer relapse. Anti-H. pylori therapy includes clarithromycin, tinidazole, and amoxicillin but not ciprofloxacin.
30 Choose the correct statement about colloidal bismuth
subcitrate: A It causes prolonged neutralization of gastric acid B. It has anti-H.pylori activity C. It relieves peptic ulcer pain promptly D. All of the above are correct (p. 597) 44.31 Eradication of H.pylori along with gastric antisecre- tory drugs affords the following benefit(s]: A Faster relief of ulcer pain B. Faster ulcer healing C. Reduced chance of ulcer relapse D. Both "B' and 'C' are correct (p. 597) 44.32 The drugs employed foranti-H.pyloritherapy include the following except: A Ciprofloxacin B. Ciarithromycin C. Tinidazole D. Amoxicillin (p. 597, 598) 44.33 The following is true of anti-H.pylori therapy except: A It is indicated in all patients of peptic ulcer B. Resistance to any single antimicrobial drug develops rapidly C. Concurrent suppression of gastric acid enhances efficacy of the regimen D. Colloidal bismuth directly inhibits H.pylori but has poor patient acceptability (p. 598) 44.34 The preferred regimen for preventing duodenal ulcer relapse is: A Maintenance antacid regimen B. Maintenance H 2 blocker regimen C. On demand intermittent H2 blocker regimen D. Maintenance sucralfate regimen (p. 598) 144.30B 44.31D 44.32A 44 . 33A 44.34B I